According to Reuters, Maravai LifeSciences (MRVI) approached by Sartorius AG
Laboratory supplies vendor Sartorius AG has approached Maravai LifeSciences Holdings Inc (MRVI), a U.S. provider of capping reagents for COVID-19 vaccines, with an $11 billion
Read More